News

ESGL Holdings Limited Shows Strong Progress in FY2024 Results

ESGL Holdings Limited Shows Strong Progress in FY2024 Results

ESGL Holdings Limited Announces Significant FY2024 Achievements

In a notable display of resilience and strategic execution, ESGL Holdings Limited (NASDAQ: ESGL) recently unveiled its financial performance for the fiscal year ending December 31, 2024. The filing of the Annual Report on Form 20-F highlights the company's successful pivot towards profitability and operational strength.

The results underscore the transformative journey undertaken by ESGL, a leader in sustainable waste management solutions and circular chemical production. Its subsidiaries, particularly Environmental Solutions (Asia) Pte Ltd, have played a pivotal role in this turnaround, showcasing remarkable efficiency and effectiveness throughout the fiscal year.

Key Financial Highlights from FY2024

This fiscal year showcased significant financial advancements for ESGL. Here are some key highlights from their achievements:

  • Return to profitability for Environmental Solutions (Asia) Pte Ltd
  • Net loss significantly reduced, from US$95 million in the previous fiscal year to just US$0.6 million
  • Impressive Adjusted EBITDA growth, more than doubling to reach US$2.3 million
  • Substantial decrease in loss per share, from US$14.70 to US$0.02

CEO's Vision on Sustainability and Profitability

“FY2024 was a pivotal year for ESGL,” remarked Quek Leng Chuang, CEO & Chairman of ESGL. He emphasized the potential for aligning sustainability with profitability, stating, “With a profitable core and an expanding range of circular products, we are grounded for future progress and environmental influence.” He further articulated the intent to harness these achievements for long-term growth, ensuring that sustainability continues to be at the heart of the company’s strategies.

Operational Improvements Driving Positive Outcomes

The rebound in profitability can be attributed to various operational enhancements witnessed throughout FY2024. The company benefited from reduced inventory and logistics costs, combined with the elimination of one-time expenses previously incurred in FY2023. These strategic changes have allowed ESGL to stabilize its financials while continuing to expand its innovative product range.

ESGL proudly initiated commercial sales of its latest circular products during this period. Products such as NEWSPAR, NEWEARTH, and NEWCHEM exemplify the innovative approaches being embraced through proprietary waste-to-resource methodologies, shedding light on the company’s commitment to sustainable practices.

Expansion in Southeast Asia's Market

As part of its growth trajectory, ESGL continues to enhance its capabilities within the sustainable waste treatment and circular manufacturing domains, particularly amid the rapidly evolving landscape of Southeast Asia. The region provides ample opportunities as industries increasingly align with sustainable practices, making it a prime market for ESGL's offerings.

Understanding Adjusted EBITDA and Its Importance

Adjusted EBITDA is a crucial performance indicator for ESGL that reflects net income (or loss) using GAAP principles, with adjustments for interest expenses, tax considerations, depreciation, amortization, and non-recurring expenses associated with business combinations and equity issuance. This metric highlights the company's operational effectiveness and profitability potential.

About ESGL Holdings Limited

ESGL Holdings Limited operates as an exempted holding company under the laws of the Cayman Islands. The company is at the forefront of sustainable waste management services, with a commitment to revolutionizing waste disposal through innovative technologies and environmentally responsible practices. Operations are conducted via its subsidiary, Environmental Solutions (Asia) Pte. Ltd., based in Singapore. As a progressive entity, ESGL is continuously working towards expanding its technological advancements and influence in waste management.

Frequently Asked Questions

What are the main achievements of ESGL Holdings Limited in FY2024?

ESGL showcased a remarkable turnaround, returning to profitability, significantly reducing its net loss, and achieving a notable increase in Adjusted EBITDA.

How does ESGL reflect its commitment to sustainability?

ESGL promotes sustainability through innovative waste management solutions and circular chemical production, focusing on environmental preservation and transformative practices.

What new products did ESGL launch in FY2024?

ESGL launched several new circular products, notably NEWSPAR, NEWEARTH, and NEWCHEM, developed from proprietary waste-to-resource processes.

What is Adjusted EBITDA and why is it important?

Adjusted EBITDA is a measure of operational performance that accounts for various expenses. It helps gauge a company's profitability and efficiency.

How is ESGL positioned for future growth?

With a solid foundation in profitability, cost management, and a growing portfolio of sustainable products, ESGL is strategically positioned for long-term growth in the environmental sector.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading